Menu
Log in
Log in

News

  • Home
  • Resources
  • Literature Updates
  • Utility of Initial Tumor Reduction as a Prognostic Factor in Esophageal Squamous Cell Cancer Patients Undergoing Neoadjuvant Chemotherapy Followed by Surgery

Utility of Initial Tumor Reduction as a Prognostic Factor in Esophageal Squamous Cell Cancer Patients Undergoing Neoadjuvant Chemotherapy Followed by Surgery

16 Sep 2024 10:37 AM | Anonymous member (Administrator)

Takaomi Hagi, Osamu Shiraishi, Tomoya Nakanishi, Masashi Kohda, Yoko Hiraki, Hiroaki Kato, Atsushi Yasuda, Masayuki Shinkai, Motohiro Imano & Takushi Yasuda

Read Abstract: Utility of Initial Tumor Reduction as a Prognostic Factor in Esophageal Squamous Cell Cancer Patients Undergoing Neoadjuvant Chemotherapy Followed by Surgery

Affiliated Societies



International  Interdisciplinary  Everything Esophageal


The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization. © International Society for Disease of the Esophagus – ISDE 2024 | Any unauthorized use or reproduction of the content is prohibited without explicit permission.

General Inquiries: info@isde.net
Membership Questions: membership@isde.net

Powered by Wild Apricot Membership Software